Therefore, we cocultured Treg-depleted PBMC from therapy-naive or IFN-β-treated MS patients (PBMC from healthy volunteers served as control) with isolated Treg of an independent third donor and stimulated them with anti-CD3 mAb (Figure 4A, upper panel). The gene discussed is IFNB1; the disease is myeloid sarcoma.